Oleksiejczuk suspended one year and loss of win for clomiphene
Polish light heavyweight Michal Oleksiejczuk entered the UFC on a nine-fight win streak, and won his debut, defeating Khalil Rountree at UFC 219 on December 12, 2017. It’s a tremendously promising start, but Oleksiejczuk failed an anti-doping test, for clomiphene.
The punishment was not light:
•Bout was changed from a win to a No Contest;
•One year suspension, ending December 30;
•30% of $12,000 show money, or $3600;
•Relicensing will require clean drug tests.
Further, this is from the NSAC. USADA has yet to complete its investigatory process, and could respond more harshly still.
In a sign of how thorough USADA is, Oleksizjcuk was scheduled to make his league debut vs. Ion Cutelaba, but ‘The Hulk’ failed an anti-doping test. Cutelaba has accepted a six-month suspension for volunteering that he had undergone a prohibited form of Ozone therapy.
Clomiphene has two purposes. One, many anabolic steroids convert to estrogen, which can lead to a series of unfortunate side effects including Gynecomastia, or b**** t**s; clomiphene can block estrogen from attaching to receptors. Second, the use of testosterone-based steroids suppresses the body’s natural production of testosterone; clomiphene stimulates the pituitary gland to signal the testicles to restart producing testosterone naturally.
Oleksiejczuk joins Brock Lesnar, Jon Jones, James Mulheron, Nick Roehrick, and Jesse Taylor on the list of fighters who have failed for clomiphene.